Chemclin Diagnostics Co., Ltd. (SHA:688468)
6.16
-0.01 (-0.16%)
Aug 4, 2026, 3:00 PM CST
-27.44% (1Y)
| Market Cap | 2.43B -27.4% |
| Revenue (ttm) | 324.73M -20.1% |
| Net Income | 38.33M -62.9% |
| EPS | 0.09 -65.4% |
| Shares Out | 394.59M |
| PE Ratio | 67.55 |
| Forward PE | n/a |
| Dividend | 0.13 (2.03%) |
| Ex-Dividend Date | Jun 13, 2025 |
| Volume | 3,013,227 |
| Open | 6.20 |
| Previous Close | 6.17 |
| Day's Range | 6.10 - 6.22 |
| 52-Week Range | 5.50 - 9.12 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |